The use of liposomal anthracyclines was strongly suggested as a therapeutic option for breast cancer patients. The authors concluded that this report was the first to produce a set of statements on the prevention, evaluation and monitoring of chemotherapy-induced cardiac toxicity in breast cancer patie...
W., 2022.In situ hybridization for the assessment of urokinase plasminogen activator and plasminogen activator inhibitor type‑1 in formalin‑fixed paraffin‑embedded breast cancer specimens. Int J Mol Med 49, 82.https://doi.org/10.3892/ijmm.2022.5138 ...